Louisiana State Employees Retirement System Ligand Pharmaceuticals Inc Transaction History

Louisiana State Employees Retirement System

$5.33 Billion
Q3 2024

A detailed history of Louisiana State Employees Retirement System transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Louisiana State Employees Retirement System holds 8,800 shares of LGND stock, worth $997,744. This represents 0.02% of its overall portfolio holdings.

Number of Shares

8,800

Previous 8,500 3.53%

Holding current value

$997,744

Previous $716,000 23.04%

% of portfolio

0.02%

Previous 0.01%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 23, 2024	BUY	$82.7 - $110.11 $24,810 - $33,033	300 Added 3.53%	8,800 $881,000
Q2 2024 Jul 24, 2024	BUY	$68.53 - $87.91 $27,412 - $35,164	400 Added 4.94%	8,500 $716,000
Q1 2024 Apr 23, 2024	SELL	$68.64 - $89.2 $6,864 - $8,920	-100 Reduced 1.22%	8,100 $592,000
Q4 2023 Jan 29, 2024	SELL	$49.57 - $72.63 $4,957 - $7,263	-100 Reduced 1.2%	8,200 $585,000
Q3 2023 Oct 17, 2023	SELL	$58.86 - $72.67 $17,658 - $21,801	-300 Reduced 3.49%	8,300 $497,000
Q2 2023 Jul 18, 2023	BUY	$69.53 - $79.33 $76,483 - $87,263	1,100 Added 14.67%	8,600 $620,000
Q1 2023 Apr 19, 2023	SELL	$65.67 - $77.08 $6,567 - $7,708	-100 Reduced 1.32%	7,500 $551,000
Q4 2022 Jan 24, 2023	SELL	$61.72 - $96.74 $6,172 - $9,674	-100 Reduced 1.3%	7,600 $508,000
Q3 2022 Oct 19, 2022	SELL	$0.01 - $107.56 $5 - $53,780	-500 Reduced 6.1%	7,700 $663,000
Q2 2022 Jul 20, 2022	BUY	$74.52 - $117.06 $7,452 - $11,706	100 Added 1.23%	8,200 $765,000
Q4 2021 Jan 14, 2022	BUY	$127.69 - $165.85 $12,769 - $16,585	100 Added 1.25%	8,100 $1.25 Million
Q3 2021 Oct 12, 2021	BUY	$102.33 - $144.73 $378,621 - $535,501	3,700 Added 86.05%	8,000 $1.12 Million
Q1 2021 Apr 14, 2021	BUY	$99.52 - $215.83 $29,856 - $64,749	300 Added 7.5%	4,300 $656,000
Q1 2020 Apr 13, 2020	SELL	$63.37 - $107.88 $12,674 - $21,576	-200 Reduced 4.76%	4,000 $291,000
Q4 2019 Jan 17, 2020	SELL	$96.94 - $113.59 $38,776 - $45,436	-400 Reduced 8.7%	4,200 $438,000
Q3 2019 Oct 24, 2019	SELL	$86.25 - $120.16 $34,500 - $48,064	-400 Reduced 8.0%	4,600 $458,000
Q2 2019 Jul 15, 2019	SELL	$107.38 - $129.34 $53,690 - $64,670	-500 Reduced 9.09%	5,000 $580,000
Q1 2019 Apr 15, 2019	SELL	$105.93 - $142.47 $10,593 - $14,247	-100 Reduced 1.79%	5,500 $691,000
Q4 2018 Jan 14, 2019	SELL	$128.36 - $272.13 $474,932 - $1.01 Million	-3,700 Reduced 39.78%	5,600 $760,000
Q3 2018 Oct 16, 2018	SELL	$211.18 - $274.49 $42,236 - $54,898	-200 Reduced 2.11%	9,300 $2.55 Million
Q2 2018 Jul 18, 2018	BUY	$150.77 - $207.98 $15,077 - $20,798	100 Added 1.06%	9,500 $1.97 Million
Q1 2018 Apr 18, 2018	BUY	$138.63 - $182.62 $41,589 - $54,786	300 Added 3.3%	9,400 $1.55 Million
Q4 2017 Jan 16, 2018	BUY	$128.36 - $147.04 $77,016 - $88,224	600 Added 7.06%	9,100 $1.25 Million
Q3 2017 Oct 16, 2017	BUY	$120.91 - $137.94 $1.03 Million - $1.17 Million	8,500	8,500 $1.16 Million

Others Institutions Holding LGND

# of Institutions

256

Shares Held

18.1M

Call Options Held

26.8K

Put Options Held

9.3K

View Full List

About LIGAND PHARMACEUTICALS INC

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.91B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

More about LGND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Louisiana State Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on Louisiana State Employees Retirement System with notifications on news.

Account

Louisiana State Employees Retirement System Ligand Pharmaceuticals Inc Transaction History